Meeder Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91K | Buy |
99
+4
| +4% | +$158 | ﹤0.01% | 746 |
|
|
2025
Q1 | $2.87K | Buy |
+95
| New | +$2.87K | ﹤0.01% | 838 |
|
|
2022
Q4 | – | Sell |
-186
| Closed | -$8K | – | 1371 |
|
|
2022
Q3 | $8K | Hold |
186
| – | – | ﹤0.01% | 1403 |
|
|
2022
Q2 | $7K | Hold |
186
| – | – | ﹤0.01% | 1511 |
|
|
2022
Q1 | $7K | Buy |
+186
| New | +$7K | ﹤0.01% | 1676 |
|
|
2021
Q4 | – | Sell |
-14
| Closed | – | – | 1732 |
|
|
2021
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 2555 |
|
|
2021
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 2346 |
|
|
2021
Q1 | $1K | Buy |
14
+1
| +8% | +$71 | ﹤0.01% | 2217 |
|
|
2020
Q4 | $1K | Sell |
13
-18
| -58% | -$1.39K | ﹤0.01% | 1669 |
|
|
2020
Q3 | $1K | Sell |
31
-30
| -49% | -$968 | ﹤0.01% | 1990 |
|
|
2020
Q2 | $4K | Buy |
61
+19
| +45% | +$1.25K | ﹤0.01% | 1587 |
|
|
2020
Q1 | $2K | Sell |
42
-3,574
| -99% | -$170K | ﹤0.01% | 2092 |
|
|
2019
Q4 | $219K | Buy |
3,616
+3,562
| +6,596% | +$216K | 0.01% | 577 |
|
|
2019
Q3 | $3K | Buy |
54
+27
| +100% | +$1.5K | ﹤0.01% | 1878 |
|
|
2019
Q2 | $2K | Sell |
27
-2,229
| -99% | -$165K | ﹤0.01% | 1863 |
|
|
2019
Q1 | $184K | Buy |
+2,256
| New | +$184K | 0.01% | 563 |
|
|
2018
Q3 | – | Sell |
-112
| Closed | -$4.67K | – | 1611 |
|
|
2018
Q2 | $4.67K | Buy |
+112
| New | +$4.67K | ﹤0.01% | 1290 |
|
|
2018
Q1 | – | Sell |
-309
| Closed | -$16K | – | 1640 |
|
|
2017
Q4 | $16K | Buy |
309
+265
| +602% | +$13.7K | ﹤0.01% | 995 |
|
|
2017
Q3 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 1456 |
|
|
2017
Q2 | – | Sell |
-410
| Closed | -$16K | – | 1760 |
|
|
2017
Q1 | $16K | Sell |
410
-1,333
| -76% | -$52K | ﹤0.01% | 759 |
|
|
2016
Q4 | $83K | Buy |
+1,743
| New | +$83K | 0.01% | 540 |
|